Overview Financials News + Filings Key Docs Transactions Holdings Ownership
|
UBS Group AG
> AKBA
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Akebia Therapeutics, Inc. | AKBA | 71,488 | -16,487 | 65,412,000 | 16,146,000 | $915.01 |
03/31/2023 | Akebia Therapeutics, Inc. | AKBA | 87,975 | 29,220 | 49,266,000 | 15,188,000 | $560.00 |
12/31/2022 | Akebia Therapeutics, Inc. | AKBA | 58,755 | -73,206 | 34,078,000 | 34,037,000 | $580.00 |
09/30/2022 | Akebia Therapeutics, Inc. | AKBA | 131,961 | 1,309 | 41,000 | -5,000 | $0.31 |
06/30/2022 | Akebia Therapeutics, Inc. | AKBA | 130,652 | -638,786 | 46,000 | -507,000 | $0.35 |
03/31/2022 | Akebia Therapeutics, Inc. | AKBA | 769,438 | 286,788 | 553,000 | -538,000 | $0.72 |
12/31/2021 | Akebia Therapeutics, Inc. | AKBA | 482,650 | -46,195 | 1,091,000 | -432,000 | $2.26 |
09/30/2021 | Akebia Therapeutics, Inc. | AKBA | 528,845 | 390,489 | 1,523,000 | 999,000 | $2.88 |
06/30/2021 | Akebia Therapeutics, Inc. | AKBA | 138,356 | 2,109 | 524,000 | 143,000 | $3.79 |
12/31/2020 | Akebia Therapeutics, Inc. | AKBA | 136,247 | -33,816 | 381,000 | -46,000 | $2.80 |
09/30/2020 | Akebia Therapeutics, Inc. | AKBA | 170,063 | 39,738 | 427,000 | -1,342,000 | $2.51 |
06/30/2020 | Akebia Therapeutics, Inc. | AKBA | 130,325 | -27,162 | 1,769,000 | 575,000 | $13.57 |
03/31/2020 | Akebia Therapeutics, Inc. | AKBA | 157,487 | -65,089 | 1,194,000 | -213,000 | $7.58 |
12/31/2019 | Akebia Therapeutics, Inc. | AKBA | 222,576 | -94,013 | 1,407,000 | 166,000 | $6.32 |
09/30/2019 | Akebia Therapeutics, Inc. | AKBA | 316,589 | 61,680 | 1,241,000 | 7,000 | $3.92 |
06/30/2019 | Akebia Therapeutics, Inc. | AKBA | 254,909 | 107,075 | 1,234,000 | 23,000 | $4.84 |
03/31/2019 | Akebia Therapeutics, Inc. | AKBA | 147,834 | -36,319 | 1,211,000 | 192,000 | $8.19 |
12/31/2018 | Akebia Therapeutics, Inc. | AKBA | 184,153 | 24,356 | 1,019,000 | -392,000 | $5.53 |
09/30/2018 | Akebia Therapeutics, Inc. | AKBA | 159,797 | 27,677 | 1,411,000 | 93,000 | $8.83 |
06/30/2018 | Akebia Therapeutics, Inc. | AKBA | 132,120 | 16,251 | 1,318,000 | -405,000 | $9.98 |
12/31/2017 | Akebia Therapeutics, Inc. | AKBA | 115,869 | 39,491 | 1,723,000 | 221,000 | $14.87 |
09/30/2017 | Akebia Therapeutics, Inc. | AKBA | 76,378 | -34,894 | 1,502,000 | -97,000 | $19.67 |
06/30/2017 | Akebia Therapeutics, Inc. | AKBA | 111,272 | -40,374 | 1,599,000 | 204,000 | $14.37 |
03/31/2017 | Akebia Therapeutics, Inc. | AKBA | 151,646 | 66,948 | 1,395,000 | 513,000 | $9.20 |
12/31/2016 | Akebia Therapeutics, Inc. | AKBA | 84,698 | -14,489 | 882,000 | -16,000 | $10.41 |
09/30/2016 | Akebia Therapeutics, Inc. | AKBA | 99,187 | 99,187 | 898,000 | 898,000 | $9.05 |
06/30/2016 | Akebia Therapeutics, Inc. | AKBA | 103,467 | 28,059 | 774,000 | 95,000 | $7.48 |
03/31/2016 | Akebia Therapeutics, Inc. | AKBA | 75,408 | 42,359 | 679,000 | 360,000 | $9.00 |
12/31/2015 | Akebia Therapeutics, Inc. | AKBA | 91,031 | 57,982 | 1,176,000 | 857,000 | $12.92 |
09/30/2015 | Akebia Therapeutics, Inc. | AKBA | 33,049 | -33,244 | 319,000 | -363,000 | $9.65 |
06/30/2015 | Akebia Therapeutics, Inc. | AKBA | 66,293 | 54,417 | 682,000 | 550,000 | $10.29 |
03/31/2015 | Akebia Therapeutics, Inc. | AKBA | 11,876 | 395 | 132,000 | -2,000 | $11.11 |
12/31/2014 | Akebia Therapeutics, Inc. | AKBA | 11,481 | 11,481 | 134,000 | 134,000 | $11.67 |
<< Prev Next >> |
|